Here, we aimed to evaluate the association of clinicopathologic characteristics and the prognostic value of PDL-1 expression and TILs, and explored the immune microenvironment by assessing their relationship, since they have been suggested as clinically applicable predictive biomarkers in surgically resectable NSCLC. The gene discussed is CD274; the disease is non-small cell lung carcinoma.